Quarterly report pursuant to Section 13 or 15(d)

Marketable Securities

v3.21.1
Marketable Securities
6 Months Ended
Feb. 28, 2021
Marketable Securities [Abstract]  
Marketable Securities

19.        Marketable Securities

 

The components of Marketable Securities were as follows:

 

 

 

 

Cost Basis

$

 

 

Unrealized

Gains $

 

 

Unrealized

Losses $

 

 

Total

$

 

August 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

Common stock

 

 

56,250

 

 

 

9,997

 

 

 

(38,584 )

 

 

 

Total

 

 

56,250

 

 

 

9,997

 

 

 

(46,926 )

 

 

19,321

 

February 28, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock

 

 

524,513

 

 

 

24,410

 

 

 

(41,362 )

 

 

 

 

Total

 

 

524,513

 

 

 

34,407

 

 

 

(88,288 )

 

 

470,632

 

 

During the period ended February 28, 2021, the Company added $468,263 in marketable securities as a component of the sale of assets (Note 20).

 

Unrealized gains and losses from common stock are due to market price movements. Management does not believe any remaining unrealized losses represent other-than-temporary impairments based on our evaluation of available evidence. The COVID-19 pandemic has caused significant market turbulence and it is possible that our evaluation will change dependent upon new information as it arises.